Association between mutations in a thyX-hsdS.1 region and para-aminosalicylic acid resistance in Mycobacterium tuberculosis clinical isolates. [PDF]
Zeng R +8 more
europepmc +1 more source
Preparation of Lipophilic Derivatives of <i>para</i>-Aminosalicylic Acid for Antimicrobial Drug Design. [PDF]
Hearn MJ, Min AK.
europepmc +1 more source
The aim was to evaluate the effect of 5-aminosalicylic acid on myocardial capillary permeability for small hydrophilic molecules after ischaemia and ...
Høst, N B +4 more
core
Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey". [PDF]
Limsrivilai J, Leung WK.
europepmc +1 more source
Association of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5-Aminosalicylic Acid in Patients With Ulcerative Colitis. [PDF]
Otagiri S +4 more
europepmc +1 more source
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid. [PDF]
Yarur A +14 more
europepmc +1 more source
Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines. [PDF]
Looser R +7 more
europepmc +1 more source
5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis. [PDF]
Wada H +12 more
europepmc +1 more source
Anti-Psoriatic Effects of J2H-1802, a Mycophenolate Mofetil and 5-Aminosalicylic Acid Hybrid, in an Imiquimod-Induced Psoriasis-like Mouse Model. [PDF]
Park SH +10 more
europepmc +1 more source
Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data. [PDF]
Ungaro RC +4 more
europepmc +1 more source

